NONALCOHOLIC FATTY LIVER DISEASE
Clinical trials for NONALCOHOLIC FATTY LIVER DISEASE explained in plain language.
Never miss a new study
Get alerted when new NONALCOHOLIC FATTY LIVER DISEASE trials appear
Sign up with your email to follow new studies for NONALCOHOLIC FATTY LIVER DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can vitamin e tame fatty liver? new study tests the right dose
Disease control CompletedThis study tested different doses of vitamin E in 200 adults with nonalcoholic fatty liver disease (NAFLD) to find the best dose for improving liver health. Participants took vitamin E or a placebo for 24 weeks, and researchers measured changes in a key liver enzyme (ALT). The go…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New drug shows promise in shrinking fatty liver
Disease control CompletedThis study tested a drug called efinopegdutide in 124 adults with a type of fatty liver disease (MASLD). The goal was to see if taking the drug every two weeks or every week could safely reduce fat in the liver over 28 weeks. The study also looked at weight loss and side effects.
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
New drug shows promise against fatty liver disease in major trial
Disease control CompletedThis study tested a new medicine called efinopegdutide in 381 adults with non-alcoholic steatohepatitis (NASH), a serious fatty liver disease. The main goal was to see if the drug could reverse liver inflammation without making scarring worse, compared to a placebo. Researchers a…
Matched conditions: NONALCOHOLIC FATTY LIVER DISEASE
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 10, 2026 13:25 UTC